GSA Capital Partners’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-55,059
Closed -$619K 1747
2025
Q2
$619K Sell
55,059
-73,514
-57% -$570K 0.04% 767
2025
Q1
$733K Buy
+128,573
New +$1.31M 0.07% 535
2024
Q4
Sell
-120,169
Closed -$979K 1694
2024
Q3
$979K Buy
120,169
+50,282
+72% +$504K 0.07% 480
2024
Q2
$935K Buy
+69,887
New +$2.09M 0.07% 549
2023
Q4
Sell
-1,899
Closed -$138K 1582
2023
Q3
$138K Buy
+1,899
New +$152K 0.01% 1355
2023
Q2
Sell
-1,815
Closed -$97K 1600
2023
Q1
$97K Sell
1,815
-1,136
-38% -$72K 0.01% 1364
2022
Q4
$199K Buy
2,951
+302
+11% +$27.8K 0.02% 1190
2022
Q3
$331K Sell
2,649
-3,447
-57% -$411K 0.04% 860
2022
Q2
$580K Buy
+6,096
New +$744K 0.09% 408
2022
Q1
Sell
-661
Closed -$220K 1500
2021
Q4
$220K Buy
+661
New +$314K 0.03% 1150

Other funds holding DNA